Green Cross Holdings Corporation

KOSE:A005257 Stock Report

Market Cap: ₩764.2b

Green Cross Holdings Past Earnings Performance

Past criteria checks 0/6

Green Cross Holdings's earnings have been declining at an average annual rate of -59%, while the Biotechs industry saw earnings growing at 2.7% annually. Revenues have been growing at an average rate of 7.7% per year.

Key information

-59.0%

Earnings growth rate

-59.0%

EPS growth rate

Biotechs Industry Growth11.7%
Revenue growth rate7.7%
Return on equity-5.7%
Net Margin-3.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Green Cross Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSE:A005257 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,181,325-67,892427,836161,802
30 Jun 242,113,064-75,257428,949162,912
31 Mar 242,089,633-68,156426,954168,083
31 Dec 232,057,936-53,448419,632179,470
30 Sep 232,022,765-4,483426,536196,019
30 Jun 232,034,7386,689418,054204,932
31 Mar 232,015,4899,763416,239208,850
31 Dec 222,079,56033,457408,479193,945
30 Sep 222,080,21014,585401,716184,627
30 Jun 222,057,37232,002395,429177,894
31 Mar 221,997,19739,712388,835154,316
31 Dec 211,840,55954,901376,468147,282
30 Sep 211,839,7429,620361,495147,785
30 Jun 211,775,10029,238347,233135,340
31 Mar 211,722,66565,565319,163141,602
31 Dec 201,719,32660,806301,464143,311
30 Sep 201,612,25396,771270,036128,912
30 Jun 201,540,22072,006251,017127,916
31 Mar 201,488,62448,269225,374127,162
31 Dec 191,493,58942,741221,067126,347
30 Sep 191,492,85229,228222,126122,954
30 Jun 191,496,67718,310221,204124,867
31 Mar 191,551,002-222227,157124,320
31 Dec 181,548,71518,465221,863122,405
30 Sep 181,519,20826,751204,758119,275
30 Jun 181,522,76638,297198,275115,068
31 Mar 181,494,55059,556191,544108,345
31 Dec 171,465,48943,364185,640103,749
30 Sep 171,479,23562,679178,320108,474
30 Jun 171,433,08455,552173,950109,047
31 Mar 171,397,33150,325175,393110,624
31 Dec 161,354,46647,177172,994109,210
30 Sep 161,272,15725,266174,099109,676
30 Jun 161,224,59547,651167,153101,413
31 Mar 161,169,78157,849159,51297,034
31 Dec 151,132,87765,421154,01595,507
30 Sep 151,106,56366,458148,70083,567
30 Jun 151,093,49364,003149,36280,311
31 Mar 151,057,32252,063144,30375,281
31 Dec 141,044,76856,761141,52975,014
30 Sep 141,030,19454,428134,89974,901
30 Jun 141,006,09543,922128,92676,938
31 Mar 14973,48643,473125,95675,662
31 Dec 13938,29843,550123,46972,961

Quality Earnings: A005257 is currently unprofitable.

Growing Profit Margin: A005257 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A005257 is unprofitable, and losses have increased over the past 5 years at a rate of 59% per year.

Accelerating Growth: Unable to compare A005257's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A005257 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.9%).

Return on Equity

High ROE: A005257 has a negative Return on Equity (-5.65%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:20
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Green Cross Holdings Corporation is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sang-Hun LeeiM Securities
Jae Hyun KwonMirae Asset Securities Co., Ltd.
Ji-Won ShinMirae Asset Securities Co., Ltd. (Pre-Merger)